1990
DOI: 10.1097/00000542-199011000-00011
|View full text |Cite
|
Sign up to set email alerts
|

Chloroprocaine Antagonism of Epidural Opioid Analgesia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
1

Year Published

1991
1991
2023
2023

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 38 publications
(10 citation statements)
references
References 0 publications
0
9
1
Order By: Relevance
“…21 The mechanism of this interaction is unclear, but appears to involve one subset of spinal opioid receptors, as it does not occur when chloroprocaine is combined with kappa-agonist opioids. 20 While our previous study supported a positive interaction between fentanyl and procaine in intensifying block and reducing the failure rate, the current data suggest that there is another undefined interaction that adversely impacts the frequency and severity of pruritus.…”
Section: Discussioncontrasting
confidence: 50%
“…21 The mechanism of this interaction is unclear, but appears to involve one subset of spinal opioid receptors, as it does not occur when chloroprocaine is combined with kappa-agonist opioids. 20 While our previous study supported a positive interaction between fentanyl and procaine in intensifying block and reducing the failure rate, the current data suggest that there is another undefined interaction that adversely impacts the frequency and severity of pruritus.…”
Section: Discussioncontrasting
confidence: 50%
“…A recent study by our own group attempted to examine this drug interaction further. 9 We suggested that 2-CP may be a pure mu-receptor antagonist, inasmuch as epidural butorphanol (a kappareceptor agonist) showed a similar analgesic profile after either lidocaine or 2-CP anaesthesia. However, that study did not assess the possible contribution of supraspinal (i.e., systemic) effects of the epidural butorphanol.…”
Section: Discussionmentioning
confidence: 89%
“…Epidurally administered nalbuphine reported satisfactory outcome with regard to quality of analgesia and incidence of serious complications 13,14,15 . In the present study also there was no respiratory depression and nausea and vomiting; however, PaCO2 level were not monitored.…”
Section: Discussionmentioning
confidence: 93%